In each of the two pivotal phase 3 trials, women aged 40 to 65 years with confirmed menopausal vasomotor symptoms (average seven moderate-to-severe VMS/day) took 30 or 45 mg fezolinetant per day
Timing, storage, and their effect on dosing accuracy Dosing accuracy is not just about reading your syringe correctly
There is currently not enough research on the sexual health effects of these medications to draw complete conclusions
Some individuals tolerate one option better than the other
Hydration is equally critical because dehydration can amplify nausea, reduce energy, and slow metabolism
Also, high treatment costs, supply constraints, and increasing competition from new obesity and diabetes therapies hinder the market